MediciNova, Inc. (MNOV) — Financial statements
Income statement, balance sheet, and cash flow for MediciNova, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.41 | 0.00↓100.0% | 1 | 0.00↓100.0% | 4 | |
| Cost of Revenue | 0.38 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Gross Profit | 0.03 | 0.00↓100.0% | 1 | 0.00↓100.0% | 4 | |
| Operating Expenses | ||||||
| R&D Expenses | 7↓0.6% | 7↑27.2% | 6↓38.1% | 9↑12.9% | 8 | |
| General & Administrative Expenses | 6↑17.9% | 5↑4.8% | 5↓4.8% | 5↓4.6% | 5 | |
| Selling & Marketing Expenses | 0.00↓100.0% | 0.26↑0.3% | 0.26↑3.7% | 0.25↑8.7% | 0.23 | |
| SG&A Expenses | 6↑12.4% | 5↑4.5% | 5↓4.4% | 5↓4.0% | 6 | |
| Other Expenses | 0.00↑100.0% | -0.00↓3.3% | -0.00↓203.1% | 0.00↓99.9% | 0.44 | |
| Operating Expenses | 13↑5.0% | 13↑16.3% | 11↓25.5% | 15↑2.6% | 14 | |
| Total Costs & Expenses | 14↑8.0% | 13↑16.3% | 11↓25.5% | 15↑2.6% | 14 | |
| Operating Results | ||||||
| Operating Income | -13↓4.8% | -13↓28.0% | -10↑32.3% | -15↓43.2% | -10 | |
| Depreciation & Amortization | 0.02↓4.6% | 0.02↑3.9% | 0.02↑14.6% | 0.02↓32.3% | 0.03 | |
| EBITDA | -12↑5.4% | -13↓28.1% | -10↑32.4% | -15↓43.4% | -10 | |
| EBIT | -12↑5.4% | -13↓28.0% | -10↑32.3% | -15↓43.2% | -10 | |
| Interest & Other Income | ||||||
| Net Interest Income | 1↓22.0% | 2↓8.9% | 2↑126.6% | 0.81↑463.7% | 0.14 | |
| Interest Income | 1↓22.0% | 2↓8.9% | 2↑126.6% | 0.81↑463.7% | 0.14 | |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Non-Operating Income | -1 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Income / Expenses | 1↓20.9% | 2↑22.5% | 1↑136.8% | 0.56↑568.5% | 0.08 | |
| Income Before Tax | -12↓8.6% | -11↓28.9% | -9↑39.1% | -14↓38.8% | -10 | |
| Income Tax Expense | 0.01↑8.3% | 0.01↑81.7% | 0.00↑8.0% | 0.00↑9.9% | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -12↓8.6% | -11↓28.9% | -9↑39.1% | -14↓38.8% | -10 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -12↓8.6% | -11↓28.9% | -9↑39.1% | -14↓38.8% | -10 | |
| Bottom-Line Net Income | -12↓8.6% | -11↓28.9% | -9↑39.1% | -14↓38.8% | -10 | |
| EPS (Basic) | -0.24↓4.3% | -0.23↓35.3% | -0.17↑41.4% | -0.29↓38.1% | -0.21 | |
| EPS (Diluted) | -0.24↓4.3% | -0.23↓35.3% | -0.17↑41.4% | -0.29↓38.1% | -0.21 | |
| Weighted Average Shares | 49↑0.0% | 49↑0.0% | 49↑0.0% | 49↑0.9% | 49 | |
| Weighted Average Diluted Shares | 49↑0.0% | 49↑0.0% | 49↑0.0% | 49↑0.9% | 49 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.